Kyntra Bio, Inc. (KYNB) Tops Q2 EPS by 614c

Kyntra Bio, Inc. (NASDAQ: KYNB) reported Q2 EPS of $2.96, $6.14 better than the analyst estimate of ($3.18).

For earnings history and earnings-related data on Kyntra Bio, Inc. (KYNB) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Nike (NKE) calls more active than puts into upcoming quarter results
• Citi Upgrades Formosa Petrochemical Corp. (6505:TT) to Buy